Bernard J. Zovighian, CEO at Edwards Lifesciences Corp (EW), sold 54,563 shares at $83.45 ($4.3M) on 2025-12-10, disclosed to the SEC on 2025-12-10.
Scheduled sale ($4.3M) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.21 | 21,487 | $1.8M | 42.5% |
| 2 | $85.21 | 21,487 | $1.8M | 42.5% |
| 3 | $0.00 | 3,863 | $0 | 0.0% |
| 4 | $83.45 | 3,863 | $322K | 7.5% |
| 5 | $83.45 | 3,863 | $322K | 7.5% |
| Total | $78.93 avg | 54,563 |
| $4.3M |
| 100% |
| Filing → |
| EW | SELL | 2026-05-12 | $2.8M | — | Filing → |
| EW | SELL | 2026-02-13 | $3.4M | — | Filing → |
| EW | SELL | 2025-06-03 | $2.6M | — | Filing → |